NBA: Celtics C Kristaps Porzingis (plantar fasciitis) out 4-6 weeks

Date:

Share post:


Boston Celtics center Kristaps Porzingis will spend the next four to six weeks rehabbing his right foot after being diagnosed with plantar fasciitis, the team announced Wednesday.

The veteran big man, acquired in a three-team trade from the Washington Wizards in June, is expected to be ready for the start of training camp.

The foot injury forced Porzingis to announce Tuesday that he won’t compete for Latvia at the upcoming FIBA Basketball World Cup.

Porzingis, 28, averaged a career-best 23.2 points for the Wizards last season as well as 8.4 rebounds, 2.7 assists and 1.5 blocks in 65 games. He also shot a career-best 49.8 percent from the floor, with his 38.5 percent accuracy on 3-pointers the second best of his career.

A 2017-18 All-Star, Porzingis has averaged 19.6 points and 7.9 rebounds in seven seasons with the New York Knicks (2015-18), Dallas Mavericks (2019-22) and Wizards (2022-23).

Porzingis exercised the $36 million option on his contract for the upcoming season to facilitate the trade that saw guard Marcus Smart dealt to the Memphis Grizzlies.

Boston later signed Porzingis to a two-year extension that runs through the 2025-26 season.

–Field Level Media

spot_img

Related articles

WNCAAB: Women’s Top 25 roundup: No. 4 USC hands No. 8 Maryland first loss

Kennedy Smith produced a personal 7-0 run to tie the game midway through the fourth quarter, and No....

NCAAB: Top 25 roundup: Villanova ends No. 9 UConn’s win streak

Eric Dixon scored 18 of his 23 points in the second half to propel host Villanova to a...

NCAAB: Andrej Stojakovic, Cal pull away from Virginia

Andrej Stojakovic had a game-high 23 points, including seven in a game-breaking spurt to start the second half,...

NCAAB: No. 11 Kansas rides strong second half to beat Arizona State

Zeke Mayo scored 23 points on 8-of-14 shooting to lead No. 11 Kansas to a 74-55 win over...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.